Managing severe pain and abuse potential: the potential impact of a new abuse-deterrent formulation oxycodone/naltrexone extended-release product

Journal of Pain Research ◽

10.2147/jpr.s127602 ◽

2018 ◽

Vol Volume 11 ◽

pp. 301-311 ◽

Cited By ~ 6

Author(s):

Joseph Pergolizzi, Jr. ◽

Robert Taylor Jr ◽

Jo Ann LeQuang ◽

Robert B Raffa

Keyword(s):

Severe Pain ◽

Extended Release ◽

Abuse Potential ◽

Potential Impact ◽

Release Product

Download Full-text

(444) Clinical results of an abuse potential study with REMOXY®, an abuse deterrent, extended release product

Journal of Pain ◽

10.1016/j.jpain.2016.01.421 ◽

2016 ◽

Vol 17 (4) ◽

pp. S85

Author(s):

L. Webster ◽

N. Friedmann

Keyword(s):

Extended Release ◽

Clinical Results ◽

Abuse Potential ◽

Potential Study ◽

Release Product

Download Full-text

Poster 427 Pharmacodynamic Effects From a Category 3 Intranasal Human Abuse Potential Study of an Abuse-Deterrent, Extended-Release Morphine Product Candidate in Nondependent, Recreational Opioid Users

PM&R ◽

10.1016/j.pmrj.2016.07.352 ◽

2016 ◽

Vol 8 (9) ◽

pp. S300-S301

Author(s):

Lynn R. Webster ◽

Michael D. Smith ◽

John Lawler ◽

Karsten Lindhardt ◽

Jeffrey M. Dayno

Keyword(s):

Extended Release ◽

Abuse Potential ◽

Pharmacodynamic Effects ◽

Potential Study ◽

Product Candidate ◽

Opioid Users

Download Full-text

The Abuse Potential of Remoxy®, an Extended-Release Formulation of Oxycodone, Compared with Immediate- and Extended-Release Oxycodone

Pain Medicine ◽

10.1111/j.1526-4637.2011.01093.x ◽

2011 ◽

Vol 12 (4) ◽

pp. 618-631 ◽

Cited By ~ 34

Author(s):

Beatrice Setnik ◽

Carl L. Roland ◽

Jody M. Cleveland ◽

Lynn Webster

Keyword(s):

Extended Release ◽

Abuse Potential ◽

Release Formulation ◽

Extended Release Formulation

Download Full-text

Effectiveness and safety of morphine sulfate extended-release capsules in patients with chronic, moderate-to-severe pain in a primary care setting

Journal of Pain Research ◽

10.2147/jpr.s23024 ◽

2011 ◽

pp. 373

Author(s):

Beatrice Setnik ◽

Brown ◽

Lee ◽

Cleveland ◽

Roland ◽

...

Keyword(s):

Primary Care ◽

Severe Pain ◽

Extended Release ◽

Care Setting ◽

Primary Care Setting ◽

Morphine Sulfate

Download Full-text

Evaluation of the Relative Intranasal Abuse Potential of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid Users

Pain Medicine ◽

10.1093/pm/pnx133 ◽

2017 ◽

Vol 19 (8) ◽

pp. 1597-1612

Author(s):

Mary Bond ◽

Kerri A Schoedel ◽

Laura Rabinovich-Guilatt ◽

Maciej Gasior ◽

William Tracewell ◽

...

Keyword(s):

Extended Release ◽

Abuse Potential ◽

Opioid Users ◽

Extended Release Tablet ◽

Release Tablet

Download Full-text

Extended-Release Dinalbuphine Sebacate Versus Intravenous Patient-Controlled Analgesia with Fentanyl for Postoperative Moderate-to-Severe Pain: A Randomized Controlled Trial

Pain and Therapy ◽

10.1007/s40122-020-00197-x ◽

2020 ◽

Vol 9 (2) ◽

pp. 671-681

Author(s):

Tsung-Kun Chang ◽

Ching-Wen Huang ◽

Wei-Chih Su ◽

Hsiang-Lin Tsai ◽

Cheng-Jen Ma ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Severe Pain ◽

Extended Release ◽

Controlled Trial ◽

Patient Controlled Analgesia ◽

Randomized Controlled

Download Full-text

Poster 238: Efficacy and Tolerability of ALO-01 (Morphine Sulfate Extended-Release With Sequestered Naltrexone Hydrochloride) Capsules in Patients With Chronic Moderate-to-Severe Pain From Osteoarthritis of the Hip or Knee

Archives of Physical Medicine and Rehabilitation ◽

10.1016/j.apmr.2008.09.238 ◽

2008 ◽

Vol 89 (11) ◽

pp. e97 ◽

Cited By ~ 5

Author(s):

James B. Jones ◽

Linda Fox ◽

Nathaniel Katz ◽

David Morris ◽

Joseph Stauffer

Keyword(s):

Severe Pain ◽

Extended Release ◽

Morphine Sulfate ◽

Osteoarthritis Of The Hip ◽

Naltrexone Hydrochloride

Download Full-text

A multicenter, primary-care-based, open-label study to assess the success of converting opioid-experienced patients with chronic moderate-to-severe pain to morphine sulfate and naltrexone hydrochloride extended-release capsules using a standardized conversion guide

Journal of Pain Research ◽

10.2147/jpr.s82395 ◽

2015 ◽

pp. 347

Author(s):

Vardit Dror ◽

Beatrice Setnik ◽

Carl Roland ◽

Kenneth Sommerville ◽

Glenn Pixton ◽

...

Keyword(s):

Primary Care ◽

Severe Pain ◽

Extended Release ◽

Morphine Sulfate ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Naltrexone Hydrochloride

Download Full-text

Steady-State Pharmacokinetic Comparison of a New, Extended-Release, Once-Daily Morphine Formulation, Avinza™, and a Twice-Daily Controlled-Release Morphine Formulation in Patients with Chronic Moderate-to-Severe Pain

Journal of Pain and Symptom Management ◽

10.1016/s0885-3924(02)00382-2 ◽

2002 ◽

Vol 23 (4) ◽

pp. 292-300 ◽

Cited By ~ 37

Author(s):

Russell K. Portenoy ◽

Andréa Sciberras ◽

Lise Eliot ◽

Gordon Loewen ◽

Jackie Butler ◽

...

Keyword(s):

Steady State ◽

Controlled Release ◽

Severe Pain ◽

Extended Release ◽

Once Daily

Download Full-text

Efficacy and safety of long-term, once-daily morphine sulfate extended-release capsules in cancer patients with chronic, moderate-to-severe pain

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.8075 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 8075-8075

Author(s):

E. S. Groves ◽

S. M. Shelby ◽

L. Schlosser

Keyword(s):

Cancer Patients ◽

Severe Pain ◽

Extended Release ◽

Morphine Sulfate ◽

Efficacy And Safety ◽

Once Daily

Download Full-text